suma/inflammation

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention concerns a new cosmetic preparation containing peptide derivatives derived from .alpha.-MSH (melanocyte stimulating hormone) and other active ingredients. 2. The Prior Art .alpha.-MSH has already been investigated by a number of

FIELD OF THE INVENTION The present invention relates generally to sulfated ligands and to methods of preventing the metabolic addition of a sulfate to a natural ligand or remove a sulfate to thereby prevent the attachment of the ligand to a receptor. More specifically, the invention relates to

BACKGROUND OF THE INVENTION This invention relates to a novel N-acetyl substituted aryl analog of an N-substituted benzamide, its acid addition salts, the use thereof as direct chemotherapeutic agents or as sensitizers for radiation and/or other chemotherapeutic agents in methods of inhibiting or

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to novel 2-pyridyl-tiazolidin-4-one derivatives which shown excellent antagonisms to the platelet activating factor (hereinafter abbreviated as PAF). 2. Description of the Prior Art PAF is a factor which in minute

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to a reciprocating motion platform for oscillating a subject in a back and forth, headward to footward manner in order to externally add pulses to the fluid channels of the subject. The external addition of

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to a reciprocating motion platform for oscillating a subject in a back and forth, headward to footward manner in order to externally add pulses to the fluid channels of the subject. The external addition of

SUMMARY OF INVENTION The present invention relates to novel therapeutically useful derivatives of the thiophene-2-carboxylic acid of the general formula ##STR2## in which R in position 3 or 4 is hydrogen, methyl, chlorine or bromine and R.sub.1 is hydrogen or C.sub.1 -C.sub.4 -alkyl, and the

This is a 371 of PCT/EP96/01936 filed May 9, 1996. SUBJECT OF THE INVENTION The invention relates to the subjects that are characterized in the claims, i.e., the use of nonsteroidal anti-inflammatory agents to improve the physiological compatibility of particulate pharmaceutical agent

The present invention is directed to novel 6-1H-imidazo-2-aryl and 2-heteroaryl quinazoline and quinolines, to a process for their preparation, to their pharmaceutical compositions and to the use of such compounds and their pharmaceutical compositions for the treatment of pain and inflammatory

The present invention is directed to novel 6-1H-imidazo-2-aryl and 2-heteroaryl quinazoline and quinolines, to a process for their preparation, to their pharmaceutical compositions and to the use of such compounds and their pharmaceutical compositions for the treatment of pain and inflammatory

FIELD OF THE INVENTION The present disclosure relates to the association between detecting and quantifying the presence of macrophage migration inhibitory factor (MIF) in urine, bladder and prostate tissues for the purpose of urological inflammatory disease diagnosis and prognosis. In addition,

BACKGROUND The present invention relates to anti-inflammatory compositions and, more particularly, to topical anti-inflammatory compositions. The compositions of the present invention have particular use as cosmetic and/or dermopharmaceutical compositions. Human skin is subjected to numerous

INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ELECTRONICALLY The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jun. 1, 2018, is named P14916-01_ST25.txt and

FIELD OF THE INVENTION Disclosed herein is a method for in vitro screening of nonsteroidal anti-inflammatory agents by aggregometry of dissociated sponge cells. BACKGROUND OF THE INVENTION Inflammation has several characteristic processes including permeability changes in the microvasculature,

BACKGROUND OF THE INVENTION This invention relates to topically-active anti-inflammatory 3-chloro-5,6-diaryl-1,2,4-triazines, to a method of treating inflammation, and to a composition suitable for treating inflammation. Inflammation is an essentially protective and normal response to injury,